Testosterone: a metabolic hormone in health and disease
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Testosterone is a hormone that plays a key role in carbohydrate, fat and protein metabolism. It has been known for some time that testosterone has a major influence on body fat composition and muscle mass in the male. Testosterone deficiency is associated with an increased fat mass (in particular central adiposity), reduced insulin sensitivity, impaired glucose tolerance, elevated triglycerides and cholesterol and low HDL-cholesterol. All these factors are found in the metabolic syndrome (MetS) and type 2 diabetes, contributing to cardiovascular risk. Clinical trials demonstrate that testosterone replacement therapy improves the insulin resistance found in these conditions as well as glycaemic control and also reduces body fat mass, in particular truncal adiposity, cholesterol and triglycerides. The mechanisms by which testosterone acts on pathways to control metabolism are not fully clear. There is, however, an increasing body of evidence from animal, cell and clinical studies that testosterone at the molecular level controls the expression of important regulatory proteins involved in glycolysis, glycogen synthesis and lipid and cholesterol metabolism. The effects of testosterone differ in the major tissues involved in insulin action, which include liver, muscle and fat, suggesting a complex regulatory influence on metabolism. The cumulative effects of testosterone on these biochemical pathways would account for the overall benefit on insulin sensitivity observed in clinical trials. This review discusses the current knowledge of the metabolic actions of testosterone and how testosterone deficiency contributes to the clinical disease states of obesity, MetS and type 2 diabetes and the role of testosterone replacement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448 · cited 1×
“Overproduction of proin-flammatory cytokines, other macrophage products and hormones by adipose tissue directly and indirectly induce insulin resistance (Kahn et al .”
BackgroundInflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., & Kahn, B. B. (2005) · Nature · doi:10.1038/nature03711 · Cited by 2,086
International Journal of Obesity
(2019) · International Journal of Obesity · doi:10.1038/41366.1476-5497 · Cited by 2,078
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455 · cited 6×
“Several longitudinal studies demonstrate a similar association with a low testosterone concentration independently predicting the future development of insulin resistance, MetS and T2DM (Haffner et al .”
BackgroundInfluentialItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
Graham, T. E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054862 · Cited by 1,319 · cited 1×
“2012), supporting the hypothesis that elevated expression of Rbp4 may have an important role in lipid metabolism and insulin resistance (Graham et al .”
BackgroundRegulated transport of the glucose transporter GLUT4
Bryant, N. J., Govers, R., & James, D. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm782 · Cited by 1,183
A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
Brown, M. S., & Goldstein, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11041 · Cited by 1,134
Adiponectin and protection against type 2 diabetes mellitus
Spranger, J., Kroke, A., Möhlig, M., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12255-6 · Cited by 1,120
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
Kelley, D. E., & Mandarino, L. J. (2000) · Diabetes · doi:10.2337/diabetes.49.5.677 · Cited by 1,017
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“Serine phosphorylation of IRS1, known to attenuate insulin signalling by inhibiting tyrosine phosphorylation (Aguirre et al .”
BackgroundFlier, J. S., Underhill, L. H., & Eckel, R. H. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904203201607 · Cited by 971
Signaling pathways in insulin action: molecular targets of insulin resistance
Pessin, J. E., & Saltiel, A. R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10582 · Cited by 939
Laaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791 · cited 3×
“Kapoor et al .”
Self-citationSrikanthan, P., & Karlamangla, A. S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0435 · Cited by 785
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Self-citationSystematic review and meta-analysis of psychological therapies for children with chronic pain
Fisher, E., Heathcote, L., Palermo, T. M., de C Williams, A. C., Lau, J., & Eccleston, C. (2014) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsu008 · Cited by 710
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697
Isidori, A. M., Giannetta, E., Greco, E. A., Gianfrilli, D., Bonifacio, V., Isidori, A., Lenzi, A., & Fabbri, A. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02339.x · Cited by 695
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Araujo, A. B., Dixon, J. M., Suarez, E. A., Murad, M. H., Guey, L. T., & Wittert, G. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1137 · Cited by 671
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631 · cited 2×
“Epidemiological studies have consistently reported that up to 40% of men with T2DM have testosterone deficiency (Dhindsa et al .”
BackgroundStellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618 · cited 1×
“1996, Stellato et al .”
Oh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592
The Role of Leptin in Human Obesity and Disease: A Review of Current Evidence
Mantzoros, C. S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-8-199904200-00014 · Cited by 584
Seidell, J. C., Björntorp, P., Sjöström, L., Kvist, H., & Sannerstedt, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90297-p · Cited by 567
Kupelian, V., Page, S. T., Araujo, A. B., Travison, T. G., Bremner, W. J., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1326 · Cited by 561
Leptin and Androgens in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen Levels
Isidori, A. M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.10.3673 · Cited by 559
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1233 · Cited by 548
Self-citationPitteloud, N., Hardin, M., Dwyer, A. A., Valassi, E., Yialamas, M., Elahi, D., & Hayes, F. J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2190 · Cited by 525
Adipocytokines - novel link between inflammation and vascular function?
Guzik, T. J., Gopal, D. M., & Korbut, R. (2006) · PubMed · Cited by 501
Insulin sensitivity during combined androgen blockade for prostate cancer
Smith, M. R., Lee, H., & Nathan, D. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2507 · Cited by 493
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Kapoor, D., Aldred, H., Clark, S., Channer, K. S., & Jones, T. H. (2007) · Diabetes Care · doi:10.2337/dc06-1426 · Cited by 493
Self-citationRelationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men
Pitteloud, N., Mootha, V. K., Dwyer, A. A., Hardin, M., Lee, H., Eriksson, K.-F., Tripathy, D., Yialamas, M., Groop, L., Elahi, D., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1636 · Cited by 472
Testosterone treatment and mortality in men with low testosterone levels
Shores, M. M., Smith, N. L., Forsberg, C. W., Anawalt, B. D., & Matsumoto, A. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2591 · Cited by 460
Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
Caminiti, G., Volterrani, M., Iellamo, F., Marazzi, G., Massaro, R., Miceli, M., Mammi, C., Piepoli, M., Fini, M., & Rosano, G. M. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.078 · Cited by 444
Regulation of Insulin Action by Ceramide
Stratford, S., Hoehn, K. L., Liu, F., & Summers, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406499200 · Cited by 410
Human fat cell lipolysis: biochemistry, regulation and clinical role.
Arner, P. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.004 · Cited by 401
Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism
Macotela, Y., Boucher, J., Tran, T. T., & Kahn, C. R. (2009) · Diabetes · doi:10.2337/db08-1054 · Cited by 401
Testosterone and Metabolic Syndrome: A Meta-Analysis Study
Corona, G., Monami, M., Rastrelli, G., Aversa, A., Tishova, Y., Saad, F., Lenzi, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01991.x · Cited by 400
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., & Zakai, N. (2010) · Circulation · doi:10.1161/circulationaha.109.192695 · Cited by 383
Boyanov, M. A., Boneva, Z., & Christov, V. G. (2003) · The Aging Male · doi:10.1080/tam.6.1.1.7 · Cited by 381
Mauras, N., Hayes, V., Welch, S., Rini, A., Helgeson, K., Dokler, M., Veldhuis, J. D., & Urban, R. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4892 · Cited by 368
Wang, C., Jackson, G., Jones, T. H., Matsumoto, A. M., Nehra, A., Perelman, M. A., Swerdloff, R. S., Traish, A., Zitzmann, M., & Cunningham, G. (2011) · Diabetes Care · doi:10.2337/dc10-2339 · Cited by 366
Self-citationEndogenous sex hormones and cardiovascular disease in men. A prospective population-based study.
Barrett-Connor, E., & Khaw, K. T. (1988) · Circulation · doi:10.1161/01.cir.78.3.539 · Cited by 366
Wang, C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2839 · Cited by 359 · cited 1×
“Other TRT studies have also reported improved body weight, BMI and waist circumference in men with MetS, T2DM and/or hypogonadism (Wang et al .”
BackgroundTestosterone deficiency, insulin resistance and the metabolic syndrome
Zitzmann, M. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.212 · Cited by 352
Heufelder, A. E., Saad, F., Bunck, M. C., & Gooren, L. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007005 · Cited by 349 · cited 3×
“Heufelder et al .”
BackgroundInfluentialKalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 341
Brand, J. S., van der Tweel, I., Grobbee, D. E., Emmelot-Vonk, M. H., & van der Schouw, Y. T. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq158 · Cited by 334 · cited 1×
“Two recent systematic reviews and meta-analyses support that endogenous total and free testosterone was lower in subjects with MetS compared with those without (Brand et al .”
BackgroundInflammatory Markers, Adiponectin, and Risk of Type 2 Diabetes in the Pima Indian
Krakoff, J., Funahashi, T., Stehouwer, C. D. A., Schalkwijk, C. G., Tanaka, S., Matsuzawa, Y., Kobes, S., Tataranni, P. A., Hanson, R. L., Knowler, W. C., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1745 · Cited by 334
Selvin, E., Feinleib, M., Zhang, L., Rohrmann, S., Rifai, N., Nelson, W. G., Dobs, A., Basaria, S., Golden, S. H., & Platz, E. A. (2007) · Diabetes Care · doi:10.2337/dc06-1579 · Cited by 333
Mårin, P., Odén, B., & Björntorp, P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.1.7829619 · Cited by 332 · cited 1×
“Nine-month testosterone treatment of hypogonadal men has been reported to produce a marked decrease in both LPL activity and triglyceride uptake in subcutaneous abdominal adipose tissue (Ma˚rin et al .”
BackgroundAdipocyte Signaling and Lipid Homeostasis: Sequelae of Insulin-Resistant Adipose Tissue
Yu, Y.-H., & Ginsberg, H. N. (2005) · Circulation Research · doi:10.1161/01.res.0000165803.47776.38 · Cited by 326
Haffner, S. M., Shaten, J., Stem, M. P., Smith, G. D., Kuller, L., & MRFIT Research Group (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008832 · Cited by 320 · cited 5×
“Several longitudinal studies demonstrate a similar association with a low testosterone concentration independently predicting the future development of insulin resistance, MetS and T2DM (Haffner et al .”
BackgroundInfluentialAndrogens, insulin resistance and vascular disease in men
Kapoor, D., Malkin, C. J., Channer, K. S., & Jones, T. H. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02299.x · Cited by 317
Self-citationAllan, C. A., Strauss, B. J. G., Burger, H. G., Forbes, E. A., & McLachlan, R. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1291 · Cited by 298
DOCKERY, F., BULPITT, C. J., AGARWAL, S., DONALDSON, M., & RAJKUMAR, C. (2003) · Clinical Science · doi:10.1042/cs1040195 · Cited by 294
The Stimulatory Effect of Leptin on the Neuroendocrine Reproductive Axis of the Monkey1
Finn, P. D., Cunningham, M. J., Pau, K.-Y. F., Spies, H. G., Clifton, D. K., & Steiner, R. A. (1998) · Endocrinology · doi:10.1210/endo.139.11.6297 · Cited by 294
The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
Traish, A. M., Guay, A., Feeley, R., & Saad, F. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.005215 · Cited by 286
Barrett-Connor, E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-807 · Cited by 281 · cited 1×
“…lipoprotein profile, characterised by high LDL and triglyceride levels (Wu & von Eckardstein 2003), and a negative correlation between serum levels of testosterone and total and LDL-C has been observed in cross-sectional studies (Barrett-Connor & Khaw 1988, Barrett-Connor 1992, Haffner et al .”
BackgroundMauras, N. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.1886 · Cited by 280
Contrasting Effects of Testosterone and Stanozolol on Serum Lipoprotein Levels
Thompson, P. D. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420080085036 · Cited by 274
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04105.x · Cited by 267
Aromatase Inhibition in the Human Male Reveals a Hypothalamic Site of Estrogen Feedback
Hayes, F. J. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3027 · Cited by 265
Swinnen, J. V., Ulrix, W., Heyns, W., & Verhoeven, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12975 · Cited by 262
Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species
Wei, Y., Chen, K., Whaley-Connell, A. T., Stump, C. S., Ibdah, J. A., & Sowers, J. R. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00561.2007 · Cited by 258
Psychobiologic Correlates of the Metabolic Syndrome and Associated Sexual Dysfunction
Corona, G., Mannucci, E., Schulman, C., Petrone, L., Mansani, R., Cilotti, A., Balercia, G., Chiarini, V., Forti, G., & Maggi, M. (2006) · European Urology · doi:10.1016/j.eururo.2006.02.053 · Cited by 256
Malkin, C. J., Pugh, P. J., Morris, P. D., Kerry, K. E., Jones, R. D., Jones, T. H., & Channer, K. S. (2004) · Heart · doi:10.1136/hrt.2003.021121 · Cited by 250 · cited 2×
“2003, Malkin et al .”
BackgroundSelf-citationCohen, P. G. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0624 · Cited by 245 · cited 1×
“The finding that obesity impairs testosterone levels while low testosterone levels promote increased fat deposition was initially proposed as the hypogonadal–obesity cycle hypothesis by Cohen (1999).”
BackgroundMetabolic and behavioral effects of high-dose, exogenous testosterone in healthy men
Bagatell, C. J. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.561 · Cited by 244
Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis
Whitsel, E. A., Boyko, E. J., Matsumoto, A. M., Anawalt, B. D., & Siscovick, D. S. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(01)00833-6 · Cited by 240 · cited 19×
“By contrast, there was no change in visceral fat mass in aged men with low testosterone levels following 6 months of transdermal TRT,yetsubcutaneousfat masswassignificantlyreducedin both the thigh and the abdominal areas when analysed by MRI (Frederiksen et al .”
BackgroundInfluentialCouillard, C. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1026 · Cited by 237 · cited 2×
“1990, Couillard et al .”
Relationship of sex hormones to lipids and lipoproteins in nondiabetic men
Haffner, S. M. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1610 · Cited by 237
Kapoor, D., Clarke, S., Stanworth, R., Channer, K. S., & Jones, T. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0737 · Cited by 234
Self-citationLaaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., & Salonen, J. T. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0970 · Cited by 230 · cited 1×
“Indeed, increased body fat is a well-known clinical feature of hypogonadism, and men with MetS at baseline are at an increased risk of developing hypogonadism based on an 11-year follow-up (Laaksonen et al .”
BackgroundHYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY
MAKHSIDA, N., SHAH, J., YAN, G., FISCH, H., & SHABSIGH, R. (2005) · Journal of Urology · doi:10.1097/01.ju.0000169490.78443.59 · Cited by 229
Huang, W.-C., Li, X., Liu, J., Lin, J., & Chung, L. W. K. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0206 · Cited by 228
Singh, A. B. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.136 · Cited by 226
Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men
Tsai, E., Boyko, E., Leonetti, D., & Fujimoto, W. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801183 · Cited by 225
Corona, G., Mannucci, E., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2008.00951.x · Cited by 223 · cited 2×
“2007 a , Corona et al .”
Effect of testosterone on abdominal adipose tissue in men.
Rebuffé-Scrive, M., Mårin, P., & Björntorp, P. A. (1991) · PubMed · Cited by 223
Simon, D. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.682 · Cited by 220
The role of kisspeptin in the control of gonadotrophin secretion
Roseweir, A. K., & Millar, R. P. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn058 · Cited by 218
Zitzmann, M., & Nieschlag, E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0620 · Cited by 216
Aging, Androgens, and the Metabolic Syndrome in a Longitudinal Study of Aging
Rodriguez, A., Muller, D. C., Metter, E. J., Maggio, M., Harman, S. M., Blackman, M. R., & Andres, R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2764 · Cited by 215
Garaulet, M., Perex-Llamas, F., Fuente, T., Zamora, S., & Tebar, F. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430657 · Cited by 213
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
Lin, H.-Y., Yu, I.-C., Wang, R.-S., Chen, Y.-T., Liu, N.-C., Altuwaijri, S., Hsu, C.-L., Ma, W.-L., Jokinen, J., Sparks, J. D., et al. (2008) · Hepatology · doi:10.1002/hep.22252 · Cited by 209
Maggio, M., Basaria, S., Ble, A., Lauretani, F., Bandinelli, S., Ceda, G. P., Valenti, G., Ling, S. M., & Ferrucci, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1097 · Cited by 200 · cited 1×
“2005, Maggio et al .”
The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone
De Pergola, G. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801280 · Cited by 198
Hamilton, E. J., Gianatti, E., Strauss, B. J., Wentworth, J., Lim-Joon, D., Bolton, D., Zajac, J. D., & Grossmann, M. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03942.x · Cited by 196
Testosterone deficiency: a risk factor for cardiovascular disease?
Jones, T. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.03.002 · Cited by 194
Self-citationAndrogen treatment of middle-aged, obese men: effects on metabolism, muscle and adipose tissues.
Mårin, P., Krotkiewski, M., & Björntorp, P. A. (1992) · PubMed · Cited by 192
Testosterone and DHEA activate the glucose metabolism-related signaling pathway in skeletal muscle
Sato, K., Iemitsu, M., Aizawa, K., & Ajisaka, R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00678.2007 · Cited by 190
Sex Steroid Hormones, Upper Body Obesity, and Insulin Resistance
Abate, N., Haffner, S. M., Garg, A., Peshock, R. M., & Grundy, S. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020567 · Cited by 187 · cited 1×
“Clinically, Abate et al .”
Androgen Deprivation Therapy in Prostate Cancer and Metabolic Risk for Atherosclerosis
Shahani, S., Braga-Basaria, M., & Basaria, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2595 · Cited by 185
Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy
Lanfranco, F., Zitzmann, M., Simoni, M., & Nieschlag, E. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02007.x · Cited by 180
Mårin, P., Lönn, L., Andersson, B., Odén, B., Olbe, L., Bengtsson, B. A., & Björntorp, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772568 · Cited by 172
Heemers, H. (2001) · Molecular Endocrinology · doi:10.1210/me.15.10.1817 · Cited by 172
Dose-Dependent Effects of Testosterone on Regional Adipose Tissue Distribution in Healthy Young Men
Woodhouse, L. J., Gupta, N., Bhasin, M., Singh, A. B., Ross, R., Phillips, J., & Bhasin, S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031492 · Cited by 171
Effect of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men
Zgliczynski, S., Ossowski, M., Slowinska-Srzednicka, J., Brzezinska, A., Zgliczynski, W., Soszynski, P., Chotkowska, E., Srzednicki, M., & Sadowski, Z. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05673-4 · Cited by 167
Vikan, T., Schirmer, H., Njølstad, I., & Svartberg, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0284 · Cited by 167
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 165
Self-citationEffect of testosterone on lipolysis in human pre-adipocytes from different fat depots
Dicker, A., Rydén, M., Näslund, E., Muehlen, I. E., Wirén, M., Lafontan, M., & Arner, P. (2004) · Diabetologia · doi:10.1007/s00125-003-1324-0 · Cited by 163
Testosterone Administration Suppresses Adiponectin Levels in Men
Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J. (2005) · Journal of Andrology · doi:10.1002/j.1939-4640.2005.tb02876.x · Cited by 162
Svartberg, J., Agledahl, I., Figenschau, Y., Sildnes, T., Waterloo, K., & Jorde, R. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.19 · Cited by 160
Swinnen, J. V. (1996) · Endocrinology · doi:10.1210/en.137.10.4468 · Cited by 154
Obesity, low testosterone levels and erectile dysfunction
Diaz‐Arjonilla, M., Schwarcz, M. G., Swerdloff, R. S., & Wang, C. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.42 · Cited by 153
Prediction of Metabolic Syndrome by Low Serum Testosterone Levels in Men
Haring, R., Völzke, H., Felix, S. B., Schipf, S., Dörr, M., Rosskopf, D., Nauck, M., Schöfl, C., & Wallaschofski, H. (2009) · Diabetes · doi:10.2337/db09-0031 · Cited by 153
Gruen, R., Hietanen, E. K., & Greenwood, M. R. C. (1978) · Metabolism · doi:10.1016/s0026-0495(78)80012-2 · Cited by 152
Nielsen, T. L., Hagen, C., Wraae, K., Brixen, K., Petersen, P. H., Haug, E., Larsen, R., & Andersen, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1847 · Cited by 149
A MULTIFUNCTIONAL ENZYME RELEVANT TO COMMON METABOLIC DISEASES
Eckel, R. H. (1989) · Cited by 149
(1999) · Psychology Press eBooks · doi:10.4324/9781410602954 · Cited by 149
Saad, F., Aversa, A., M. Isidori, A., & J. Gooren, L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912799424573 · Cited by 148 · cited 1×
“2011, Saad et al .”
Pottelbergh, I. V., Braeckman, L., Bacquer, D. D., Backer, G. D., & Kaufman, J. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00308-8 · Cited by 146
Gibney, J., Wolthers, T., Johannsson, G., Umpleby, A. M., & Ho, K. K. Y. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00483.2004 · Cited by 133
Saad, F., Gooren, L. J., Haider, A., & Yassin, A. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.002774 · Cited by 132
Hayes, F. J., DeCruz, S., Seminara, S. B., Boepple, P. A., & Crowley, W. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.1.7101 · Cited by 127
Öst, A., Danielsson, A., Lidén, M., Eriksson, U., Nystrom, F. H., & Strålfors, P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8173com · Cited by 127
Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men
Völzke, H., Aumann, N., Krebs, A., Nauck, M., Steveling, A., Lerch, M. M., Rosskopf, D., & Wallaschofski, H. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00953.x · Cited by 123
McInnes, K. J., Smith, L. B., Hunger, N. I., Saunders, P. T. K., Andrew, R., & Walker, B. R. (2012) · Diabetes · doi:10.2337/db11-1136 · Cited by 121
Hayes, F. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.53 · Cited by 119
Testosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
Stanworth, R. D., & Jones, T. H. (2008) · Frontiers of Hormone Research · doi:10.1159/000176046 · Cited by 118
Self-citationAndrogens and abdominal obesity
Mrin, P., & Arver, S. (1998) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(98)80191-2 · Cited by 116
Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity
Phillips, G. B. (1993) · Metabolism · doi:10.1016/0026-0495(93)90181-m · Cited by 116
The Stimulatory Effect of Leptin on the Neuroendocrine Reproductive Axis of the Monkey
Finn, P. D. (1998) · Endocrinology · doi:10.1210/en.139.11.4652 · Cited by 114
Androgens and metabolic syndrome: Lessons from androgen receptor knock out (ARKO) mice
Yanase, T., Fan, W., Kyoya, K., Min, L., Takayanagi, R., Kato, S., & Nawata, H. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.017 · Cited by 111
Movérare‐Skrtic, S., Venken, K., Andersson, N., Lindberg, M. K., Svensson, J., Swanson, C., Vanderschueren, D., Oscarsson, J., Gustafsson, J., & Ohlsson, C. (2006) · Obesity · doi:10.1038/oby.2006.75 · Cited by 111 · cited 1×
“2010, Jones 2010 a , b , Muraleedharan & Jones 2010, Moulana et al .”
BackgroundRole of acylCoA binding protein in acylCoA transport, metabolism and cell signaling
Knudsen, J., Jensen, M. V., Færgeman, N. J., Neergaard, T. B. F., & Gaigg, B. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006830606060 · Cited by 111
Review: Testosterone and the metabolic syndrome
Muraleedharan, V., & Jones, T. H. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810390258 · Cited by 110
Self-citationHypothesis: Kisspeptin Mediates Male Hypogonadism in Obesity and Type 2 Diabetes
George, J. T., Millar, R. P., & Anderson, R. A. (2010) · Neuroendocrinology · doi:10.1159/000299767 · Cited by 110
Testosterone and type 2 diabetes
Grossmann, M., Gianatti, E. J., & Zajac, J. D. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833919cf · Cited by 108
Role of acylCoA binding protein in acylCoA transport, metabolism and cell signaling
Knudsen, J., Jensen, M. V., Hansen, J. K., Færgeman, N. J., Neergaard, T. B. F., & Gaigg, B. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4929-1_11 · Cited by 107
Shabsigh, R., Arver, S., Channer, K. S., Eardley, I., Fabbri, A., Gooren, L., Heufelder, A., Jones, H., Meryn, S., & Zitzmann, M. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01696.x · Cited by 106
Derweesh, I. H., DiBlasio, C. J., Kincade, M. C., Malcolm, J. B., Lamar, K. D., Patterson, A. L., Kitabchi, A. E., & Wake, R. W. (2007) · BJU International · doi:10.1111/j.1464-410x.2007.07184.x · Cited by 104
Ramirez, M. E., McMurry, M. P., Wiebke, G. A., Felten, K. J., Ren, K., Meikle, A. W., & Iverius, P. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90299-7 · Cited by 102
Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy
Braga‐Basaria, M., Muller, D. C., Carducci, M. A., Dobs, A. S., & Basaria, S. S. (2006) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901471 · Cited by 101
Haidar, A., Yassin, A., Saad, F., & Shabsigh, R. (2007) · The Aging Male · doi:10.1080/13685530701653538 · Cited by 100
Aversa, A., Bruzziches, R., Francomano, D., Spera, G., & Lenzi, A. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03350341 · Cited by 99
Kley, H. K., Nieschlag, E., Wiegelmann, W., Solbach, H. G., & Krüskemper, H. L. (1975) · Acta Endocrinologica · doi:10.1530/acta.0.0790275 · Cited by 98
Metabolic sequelae associated with androgen deprivation therapy for prostate cancer
Faris, J. E., & Smith, M. R. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283391fd1 · Cited by 97
The influence of sexual hormones on lipogenesis and lipolysis in rat fat cells
Hansen, F. M., Fahmy, N., & Nielsen, J. H. (1980) · Acta Endocrinologica · doi:10.1530/acta.0.0950566 · Cited by 94
Testosterone therapy increased muscle mass and lipid oxidation in aging men
Frederiksen, L., Højlund, K., HOUGAARD, D. M., Brixen, K., & Andersen, M. (2011) · AGE · doi:10.1007/s11357-011-9213-9 · Cited by 94
Testosterone therapy decreases subcutaneous fat and adiponectin in aging men
Frederiksen, L., Højlund, K., Hougaard, D. M., Mosbech, T. H., Larsen, R., Flyvbjerg, A., Frystyk, J., Brixen, K., & Andersen, M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0565 · Cited by 93
Testosterone and cardiovascular disease in men
Morris, P., & Channer, K. S. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2012.21 · Cited by 93
The Influence of Androgen Deprivation Therapy on Metabolism in Patients with Prostate Cancer
Nishiyama, T., Ishizaki, F., Anraku, T., Shimura, H., & Takahashi, K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1611 · Cited by 92
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
JONES, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 92
Self-citationBasu, R., Man, C. D., Campioni, M., Basu, A., Nair, K. S., Jensen, M. D., Khosla, S., Klee, G., Toffolo, G., Cobelli, C., et al. (2007) · Diabetes Care · doi:10.2337/dc07-0359 · Cited by 91
Stearoyl-CoA desaturase and insulin signaling — What is the molecular switch?
Dobrzyń, P., Jazurek, M., & Dobrzyń, A. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.02.007 · Cited by 89
Saad, F., Gooren, L., Haider, A., & Yassin, A. (2007) · Archives of Andrology · doi:10.1080/01485010701730880 · Cited by 87
The Effect of Androgen Deprivation Therapy on Fasting Serum Lipid and Glucose Parameters
Yannucci, J., Manola, J., Garnick, M. B., Bhat, G., & Bubley, G. J. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.03.057 · Cited by 84
Thiruppathi, M., Palaniappan, M., & Balasubramanian, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.05.010 · Cited by 84
The Effect of Testosterone on Insulin Sensitivity in Men with Heart Failure
Malkin, C. J., Jones, T. H., & Channer, K. S. (2007) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.04.006 · Cited by 84 · cited 2×
“1) extends Cohen’s theory and explains why the body cannot respond to low testosterone levels by the normal homoeostatic compensatory production of androgens via increased gonadotrophin secretion to stimulate the testis (Jones 2007).”
BackgroundSelf-citationStanworth, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0266 · Cited by 84
Self-citationMetabolic syndrome, testosterone deficiency and erectile dysfunction never come alone
Yassin, A. A., Saad, F., & Gooren, L. J. (2008) · Andrologia · doi:10.1111/j.1439-0272.2008.00851.x · Cited by 84
Androgens and the control of lipid metabolism in human prostate cancer cells
Swinnen, J. V., & Verhoeven, G. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00187-8 · Cited by 81
Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
Jones, T. H. (2007) · European Urology Supplements · doi:10.1016/j.eursup.2007.07.002 · Cited by 80
Self-citationInvolvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo
Rosignoli, C., Nicolas, J. C., Jomard, A., & Michel, S. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.00014.x · Cited by 77
UYANIK, B. S., ARI, Z., GÜMÜS, B., YIGITOGLU, M. R., & ARSLAN, T. (1997) · Japanese Heart Journal · doi:10.1536/ihj.38.73 · Cited by 75
The Role of the CAG Repeat Androgen Receptor Polymorphism in Andrology
Zitzmann, M. (2008) · Frontiers of Hormone Research · doi:10.1159/000175843 · Cited by 74
Nettleship, J., Pugh, P., Channer, K., Jones, T., & Jones, R. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-976543 · Cited by 73
Self-citationObesity and the development of type 2 diabetes: the effects of fatty tissue inflammation
Schuster, D. (2010) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmsott.s7354 · Cited by 72
Lipoprotein distribution and composition in obesity: their association with central adiposity
Rw, J., Brulhart-Meynet, M.-C., Lehmann, T. N., & Golay, A. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800524 · Cited by 71
Chow, J. D. Y., Jones, M. E. E., Prelle, K., Simpson, E. R., & Boon, W. C. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0462 · Cited by 69
Salehzadeh, F., Rune, A., Osler, M., & Al-Khalili, L. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0497 · Cited by 66
Denti, L., Pasolini, G., Sanfelici, L., Benedetti, R., Cecchetti, A., Ceda, G. P., Ablondi, F., & Valenti, G. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb03028.x · Cited by 65
Metabolic Syndrome and Erectile Dysfunction
Schipilliti, M., Caretta, N., Palego, P., Selice, R., Ferlin, A., & Foresta, C. (2011) · Diabetes Care · doi:10.2337/dc11-0070 · Cited by 64
Heemers, H., Verrijdt, G., Organe, S., Claessens, F., Heyns, W., Verhoeven, G., & Swinnen, J. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401615200 · Cited by 63
Stumvoll, M., Jacob, S., Wahl, H. G., Hauer, B., Löblein, K., Grauer, P., Becker, R., Nielsen, M., Renn, W., & Häring, H. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6898 · Cited by 63
Barud, W., Palusiński, R., Bełtowski, J., & Wójcicka, G. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00069-2 · Cited by 60
PECQUERY, R., LENEVEU, M.-C., & GIUDICELLI, Y. (1988) · Endocrinology · doi:10.1210/endo-122-6-2590 · Cited by 54
Agledahl, I., Hansen, J., & Svartberg, J. (2008) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510801999068 · Cited by 53
Differential response of rat skeletal muscle glycogen metabolism to testosterone and estradiol
Ramamani, A., Aruldhas, M. M., & Govindarajulu, P. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-77-4-300 · Cited by 52
Metabolic Syndrome, Androgens, and Hypertension
Moulana, M., Lima, R., & Reckelhoff, J. F. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0184-0 · Cited by 51
Fat in Liver/Muscle Correlates More Strongly With Insulin Sensitivity in Rats Than Abdominal Fat
Lim, S., Son, K. R., Song, I. C., Park, H. S., Jin, C. J., Jang, H. C., Park, K. S., Kim, Y., & Lee, H. K. (2009) · Obesity · doi:10.1038/oby.2008.486 · Cited by 50
The effect of testosterone on glycogen metabolism in rat levator ani muscle
Bergamini, E., Bombara, G., & Pellegrino, C. (1969) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(69)90131-7 · Cited by 50
Sex hormones and lipoproteins in men
Kiel, D. P., Baron, J. A., Plymate, S. R., & Chute, C. G. (1989) · The American Journal of Medicine · doi:10.1016/s0002-9343(89)80480-2 · Cited by 50
Stanworth, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.03969.x · Cited by 50
Self-citationThe Effects of Hypogonadism on Body Composition and Bone Mineral Density in Type 2 Diabetic Patients
Dhindsa, S., Bhatia, V., Dhindsa, G., Chaudhuri, A., Gollapudi, G. M., & Dandona, P. (2007) · Diabetes Care · doi:10.2337/dc07-0337 · Cited by 47
Stümvoll, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3740 · Cited by 43
Effects of Male Hypogonadism on Regional Adipose Tissue Fatty Acid Storage and Lipogenic Proteins
Santosa, S., & Jensen, M. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031473 · Cited by 41 · cited 1×
“Santosa & Jensen (2012) have recently investigated the chronic effects of testosterone deficiency on adipose tissue FA storage.”
BackgroundTestosterone and metabolic syndrome: The link
Ranabir, S., Kshetrimayum, A., & Reetu, K. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.94248 · Cited by 40
Chen, X., Li, X., Hy, H., Jf, L., & Lin, J.-F. (2006) · PubMed · Cited by 39
Bergamini, E. (1975) · Endocrinology · doi:10.1210/endo-96-1-77 · Cited by 37
Birzniece, V., Meinhardt, U. J., Handelsman, D. J., & Ho, K. K. Y. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03524.x · Cited by 29
Sex steroids enhance insulin receptors and glucose oxidation in Chang liver cells
Parthasarathy, C., Renuka, V. N., & Balasubramanian, K. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.09.011 · Cited by 27
García-Arencibia, M., Dávila, N., Campión, J., Carranza, M. C., & Calle, C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.020 · Cited by 26
Wang, C., Swerdloff, R. S., Iranmanesh, A., Dobs, A. S., Snyder, P. J., Cunningham, G. R., Matsumoto, A. M., Weber, T. J., & Berman, N. (2000) · The Journal of Clinical Endocrinology & Metabolism · Cited by 26
Oestrogen improves glucose metabolism and insulin signal transduction in HepG2 cells
Xie, P., Liu, M., Yapeng, G., Lu, J., Xu, X., Zeng, W., & Song, H. (2003) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2003.03899.x · Cited by 25
Effect of sex hormones on glucose-6-phosphate dehydrogenase in rat levator ani muscle
Max, S. R., & Knudsen, J. F. (1980) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(80)90123-9 · Cited by 25
Sebaceous Gland Lipogenesis Induced by Testosterone: Early Metabolic Events
Sansone, G., Davidson, W. D., Cummings, B., et al. (1971) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12261491 · Cited by 25
ANDROGEN–OESTROGEN IMBALANCE IN MEN WITH CHRONIC ALCOHOLISM AND FATTY LIVER
Myking, O. L., Aakvaag, A., & DIGRANES, Ø. (1987) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a044667 · Cited by 23
Reis, C., Liberman, S., Pompeo, A. C. L., Srougi, M., Halpern, A., & Filho, W. J. (2009) · Clinics · doi:10.1590/s1807-59322009000800012 · Cited by 21
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Self-citationLow testosterone levels predict clinical adverse outcomes in SARS‐CoV‐2 pneumonia patients
Rastrelli, G., Di Stasi, V., Inglese, F., Beccaria, M., Garuti, M., Di Costanzo, D., Spreafico, F., Greco, G. F., Cervi, G., Pecoriello, A., et al. (2021) · Andrology · doi:10.1111/andr.12821 · Cited by 360
Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
Albertsen, P. C., Klotz, L., Tombal, B., Grady, J., Olesen, T. K., & Nilsson, J. (2014) · European Urology · doi:10.1016/j.eururo.2013.10.032 · Cited by 341
Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
Lunenfeld, B., Mskhalaya, G., Zitzmann, M., Arver, S., Kalinchenko, S., Tishova, Y., & Morgentaler, A. (2015) · The Aging Male · doi:10.3109/13685538.2015.1004049 · Cited by 312
Metadata
- Authors
- Kelly, D. M., & Jones, T. H.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2013-01-30
- Volume
- 217
- Issue
- 3
- Pages
- R25-R45
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2148478555
- Cited by
- 577
- References
- 209
- FWCI
- 25.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.